Stratus Media / Restorgenex acquires 2 biopharmaceutical companies
Collapse
X
-
Well the original post above and the hygeia website is more precise.
But if you want an explaination, here goes:
imagine something like a topical anti-androgen (a bit like finasteride/propecia) that only affects your scalp and doesn't reach the rest of your body. so no sides.Comment
-
Sounds great but they're in preclinical stages and haven't even proven it can grow hair. They showed proof of concept that it has strong androgen-receptor affinity and can inhibit androgenic effects in rat cells transfected with human androgen receptors, but they are a long way from anything that will help us.Comment
-
lol Yeah who can say when, I don't know at this precise moment, it's preclinical right now.
They had been looking for funding for a while, so hopefully they can get started now.
Yeah another one to watch out for
Will be direct competition for Cosmo's CB-03-01.
This is a good thing, of course
Hopefully they might have a bit of a race to market, to be the first topical like fin with no sides.
Anyway, I think they should both stop messing around with acne treatments and try to beat the other to the hair loss market.Comment
-
This is a good thing of course...the more people getting into the hairloss battle the better, although CB should beat this out... unless they really rushed these trials...CB will be out for acne in less than two years...and they just have to run a phase II for hairloss...so we should see CB for hairloss hit the market by late 2016 to mid 2017 granted there are no roadblocks...which I can't see there being any as the product will have already been released and went through all the hoops to be released for acne.Comment
-
Also, it is very interesting that Restorgenex dropped histogen for a product that hasn't proven itself to work...they must know something we don't.. because we all know histogen does, in fact, work..and work well at that.Comment
-
Where is it said that histogen has been dropped?Comment
-
Comment
Comment